Mon, 06 Apr 2020 11:30:00 +0000 Thu, 25 Sep 2025 07:14:07 +0000 Libsyn WebEngine 2.0 http://beaconmedic.com en Copyright 2019 Howard (Jack) West, MD http://beaconmedic.com JackWestMD@BeaconMedIC.com (JackWestMD@BeaconMedIC.com) Dr. Jack West and a wide range of guests reflect on new developments and evolving issues in cancer care, the emerging role of new technologies in medicine, and health care policy issues. Feedback and suggestions are welcomed at WestWindPodcast@BeaconMedIC.com. https://static.libsyn.com/p/assets/4/a/d/e/4ade04ca1517abc2/The_Beacon_Podcast_3000x3000_72dpi_v2a.png Howard (Jack) West, MD Cancer,Oncology,Health,Science,Medicine,Education,Howard,Jack,West,WestWind,Wind,Beacon,BeaconMedIC,Podcast,Medical,Interchange no Dr. Jack West and a wide range of guests reflect on new developments and evolving issues in cancer care, the emerging role of new technologies in medicine, and health care policy issues. Feedback and suggestions are welcomed at WestWindPodcast@BeaconMedIC.com. episodic no Cancer Care & Digital MedicineWestWindPodcast@BeaconMedIC.comHoward (Jack) West, MD Fri, 26 Jul 2019 10:30:00 +0000 We're removing the West Wind Podcast video feed. You can still watch the podcast in video format on our YouTube channel (/BeaconMedIC) or at the BeaconMedIC.com website. Thanks!

]]> We're removing the West Wind Podcast video feed. You can still watch the podcast in video format on our YouTube channel (/BeaconMedIC) or at the BeaconMedIC.com website. Thanks!

]]> 42 false full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDWe're removing the West Wind Podcast video feed. You can still watch the podcast in video format on our YouTube channel (/BeaconMedIC) or at the BeaconMedIC.com website. Thanks! Wed, 24 Jul 2019 11:00:00 +0000 Drs. Hossein Borghaei and host Jack West discuss long term outcomes in lung cancer with immunotherapy, potential utility of IO combinations, and when we can consider patients doing well on immunotherapy as cured if doing well beyond 5 years.

]]> Drs. Hossein Borghaei and host Jack West discuss long term outcomes in lung cancer with immunotherapy, potential utility of IO combinations, and when we can consider patients doing well on immunotherapy as cured if doing well beyond 5 years.

]]> 26:23 false 47 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDrs. Hossein Borghaei and host Jack West discuss long term outcomes in lung cancer with immunotherapy, potential utility of IO combinations, and when we can consider patients doing well on immunotherapy as cured if doing well beyond 5 years. Mon, 22 Jul 2019 11:00:00 +0000 Dr. Hossein Borghaei sits with Dr. Jack West and traces his difficult journey from war-torn Iran to Germary and then the US, which he made alone as a 16 year-old before having the opportunity to pursue medicine & his career in thoracic oncology.

]]> Dr. Hossein Borghaei sits with Dr. Jack West and traces his difficult journey from war-torn Iran to Germary and then the US, which he made alone as a 16 year-old before having the opportunity to pursue medicine & his career in thoracic oncology.

]]> 30:43 false 46 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Hossein Borghaei sits with Dr. Jack West and traces his difficult journey from war-torn Iran to Germary and then the US, which he made alone as a 16 year-old before having the opportunity to pursue medicine & his career in thoracic oncology. Fri, 19 Jul 2019 11:00:00 +0000 Dr. West questions Dr. Gideon Blumenthal of the FDA about how he and his team there struggle to provide timely access to emerging cancer treatments, while also debating questions of the proper thresholds for efficacy and safety.

]]> Dr. West questions Dr. Gideon Blumenthal of the FDA about how he and his team there struggle to provide timely access to emerging cancer treatments, while also debating questions of the proper thresholds for efficacy and safety.

]]> 20:16 false 45 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. West questions Dr. Gideon Blumenthal of the FDA about how he and his team there struggle to provide timely access to emerging cancer treatments, while also debating questions of the proper thresholds for efficacy and safety. Wed, 17 Jul 2019 11:00:00 +0000 Drs. Gideon Blumenthal & Jack West discuss his early career interests and trajectory from medical oncology training at the NIH to joining the Federal Drug Administration (FDA) to regulate oncology drugs.

]]> Drs. Gideon Blumenthal & Jack West discuss his early career interests and trajectory from medical oncology training at the NIH to joining the Federal Drug Administration (FDA) to regulate oncology drugs.

]]> 24:51 false 44 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDrs. Gideon Blumenthal & Jack West discuss his early career interests and trajectory from medical oncology training at the NIH to joining the Federal Drug Administration (FDA) to regulate oncology drugs. Mon, 15 Jul 2019 11:00:00 +0000 Dr. Jack West provides a brief summary of key findings & limitations of two new papers just out in JAMA Oncology (Theelen et al & Bauml et al.) that evaluate the potential benefit of preceding immunotherapy with radiation in patients with advanced NSCLC.

]]> Dr. Jack West provides a brief summary of key findings & limitations of two new papers just out in JAMA Oncology (Theelen et al & Bauml et al.) that evaluate the potential benefit of preceding immunotherapy with radiation in patients with advanced NSCLC.

]]> 18:01 false 43 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Jack West provides a brief summary of key findings & limitations of two new papers just out in JAMA Oncology (Theelen et al & Bauml et al.) that evaluate the potential benefit of preceding immunotherapy with radiation in patients with advanced NSCLC. Fri, 12 Jul 2019 11:00:00 +0000 Dr. Jack West speaks with Dr. Sandip Patel about how molecular oncology has changed outcomes in cancer care, but also how we face great difficulty in getting the knowledge & practice patterns out to communities.

]]> Dr. Jack West speaks with Dr. Sandip Patel about how molecular oncology has changed outcomes in cancer care, but also how we face great difficulty in getting the knowledge & practice patterns out to communities.

]]> 31:50 false 42 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Jack West speaks with Dr. Sandip Patel about how molecular oncology has changed outcomes in cancer care, but also how we face great difficulty in getting the knowledge & practice patterns out to communities. Wed, 10 Jul 2019 11:00:00 +0000 Drs. Sandip Patel & host Jack West track his early interest in medicine and even oncology & the importance of good communication & value of effective use of language when working with patients with cancer.

]]> Drs. Sandip Patel & host Jack West track his early interest in medicine and even oncology & the importance of good communication & value of effective use of language when working with patients with cancer.

]]> 20:47 false 41 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDrs. Sandip Patel & host Jack West track his early interest in medicine and even oncology & the importance of good communication & value of effective use of language when working with patients with cancer. Mon, 08 Jul 2019 11:00:00 +0000 Dr. West speaks with Dr. Suzanne Dahlberg about her path into biostatistics, leadership in shaping trials with ECOG & Dana Farber Cancer Institute, & changing endpoints & trial designs in an era of molecular oncology.

]]> Dr. West speaks with Dr. Suzanne Dahlberg about her path into biostatistics, leadership in shaping trials with ECOG & Dana Farber Cancer Institute, & changing endpoints & trial designs in an era of molecular oncology.

]]> 31:37 false 40 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. West speaks with Dr. Suzanne Dahlberg about her path into biostatistics, leadership in shaping trials with ECOG & Dana Farber Cancer Institute, & changing endpoints & trial designs in an era of molecular oncology. Fri, 05 Jul 2019 11:00:00 +0000 Host Dr. Jack West questions Dr. Puneeth Iyengar, radiation oncologist at UT-Southwestern, about proton beam radiation therapy, risks & benefits of cranial irradiation, & local ablative therapy for local consolidation therapy for oligometastatic disease.

]]> Host Dr. Jack West questions Dr. Puneeth Iyengar, radiation oncologist at UT-Southwestern, about proton beam radiation therapy, risks & benefits of cranial irradiation, & local ablative therapy for local consolidation therapy for oligometastatic disease.

]]> 31:40 false 39 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDHost Dr. Jack West questions Dr. Puneeth Iyengar, radiation oncologist at UT-Southwestern, about proton beam radiation therapy, risks & benefits of cranial irradiation, & local ablative therapy for local consolidation therapy for oligometastatic disease. Wed, 03 Jul 2019 11:00:00 +0000 Dr. Puneeth Iyengar talks with Dr. Jack West about growing up Indian in Louisiana, his training path from Boston to New York before returning to Texas, his entry into radiation oncology, & how the field is adapting to changes in cancer care.

]]> Dr. Puneeth Iyengar talks with Dr. Jack West about growing up Indian in Louisiana, his training path from Boston to New York before returning to Texas, his entry into radiation oncology, & how the field is adapting to changes in cancer care.

]]> 26:59 false 38 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Puneeth Iyengar talks with Dr. Jack West about growing up Indian in Louisiana, his training path from Boston to New York before returning to Texas, his entry into radiation oncology, & how the field is adapting to changes in cancer care. Mon, 01 Jul 2019 11:00:00 +0000 Dr. Jack West speaks with Dr. Esther Choo, academic ER specialist at OHSU in Portland, about her commitment to gender equity in medicine, gender & racial disparities, social & mass media outreach, & her leadership in the Times Up Healthcare movement.

]]> Dr. Jack West speaks with Dr. Esther Choo, academic ER specialist at OHSU in Portland, about her commitment to gender equity in medicine, gender & racial disparities, social & mass media outreach, & her leadership in the Times Up Healthcare movement.

]]> 23:00 false 37 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Jack West speaks with Dr. Esther Choo, academic ER specialist at OHSU in Portland, about her commitment to gender equity in medicine, gender & racial disparities, social & mass media outreach, & her leadership in the Times Up Healthcare movement. Fri, 28 Jun 2019 11:00:00 +0000 Dr. Esther Choo, ER Physician at OHSU in Portland, speaks with Dr. Jack West about being an outsider growing up, as well as her path into medicine & interest in emergency medicine, where care intersects with broad social issues.

]]> Dr. Esther Choo, ER Physician at OHSU in Portland, speaks with Dr. Jack West about being an outsider growing up, as well as her path into medicine & interest in emergency medicine, where care intersects with broad social issues.

]]> 21:33 false 36 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Esther Choo, ER Physician at OHSU in Portland, speaks with Dr. Jack West about being an outsider growing up, as well as her path into medicine & interest in emergency medicine, where care intersects with broad social issues. Wed, 26 Jun 2019 11:00:00 +0000 Drs. William Dale & Jack West, both from City of Hope Comprehensive Cancer Center, reflect on the challenges of having patients & fellow health care professionals welcome integration of supportive care alongside aggressive anti-cancer treatments.

]]> Drs. William Dale & Jack West, both from City of Hope Comprehensive Cancer Center, reflect on the challenges of having patients & fellow health care professionals welcome integration of supportive care alongside aggressive anti-cancer treatments.

]]> 20:25 false 35 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDrs. William Dale & Jack West, both from City of Hope Comprehensive Cancer Center, reflect on the challenges of having patients & fellow health care professionals welcome integration of supportive care alongside aggressive anti-cancer treatments. Mon, 24 Jun 2019 11:00:00 +0000 Dr. William Dale from City of Hope Comprehensive Cancer Center discusses with host Jack West how he became interested in supportive care & geriatric oncology, as well as societal biases in treating older patients.

]]> Dr. William Dale from City of Hope Comprehensive Cancer Center discusses with host Jack West how he became interested in supportive care & geriatric oncology, as well as societal biases in treating older patients.

]]> 25:46 false 34 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. William Dale from City of Hope Comprehensive Cancer Center discusses with host Jack West how he became interested in supportive care & geriatric oncology, as well as societal biases in treating older patients. Fri, 21 Jun 2019 11:00:00 +0000 Dr. Chadi Nabhan & host Jack West consider the challenge of pruning career activities after struggling to define priorities & say no to opportunities; Dr. Nabhan reviews the value of real world evidence in evaluating cancer treatments.

]]> Dr. Chadi Nabhan & host Jack West consider the challenge of pruning career activities after struggling to define priorities & say no to opportunities; Dr. Nabhan reviews the value of real world evidence in evaluating cancer treatments.

]]> 19:39 false 33 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Chadi Nabhan & host Jack West consider the challenge of pruning career activities after struggling to define priorities & say no to opportunities; Dr. Nabhan reviews the value of real world evidence in evaluating cancer treatments. Wed, 19 Jun 2019 11:00:00 +0000 Dr. Chadi Nabhan speaks with host Jack West & reviews his circuitous course from medical training in Syria to lymphoma specialist & rising administrator in Chicago to his decision to pursue an MBA, leading him into a world of the business of health care.

]]> Dr. Chadi Nabhan speaks with host Jack West & reviews his circuitous course from medical training in Syria to lymphoma specialist & rising administrator in Chicago to his decision to pursue an MBA, leading him into a world of the business of health care.

]]> 23:19 false 32 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Chadi Nabhan speaks with host Jack West & reviews his circuitous course from medical training in Syria to lymphoma specialist & rising administrator in Chicago to his decision to pursue an MBA, leading him into a world of the business of health care. Mon, 17 Jun 2019 11:00:00 +0000 Lecia Sequist, MD, MPH of Massachusetts General Hospital & Harvard Medical School debriefs with host Dr. Jack West about key ASCO 2019 findings in EGFR mutation-positive NSCLC & her campaign for the IASLC Board of Directors.

]]> Lecia Sequist, MD, MPH of Massachusetts General Hospital & Harvard Medical School debriefs with host Dr. Jack West about key ASCO 2019 findings in EGFR mutation-positive NSCLC & her campaign for the IASLC Board of Directors.

]]> 23:57 false 31 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDLecia Sequist, MD, MPH of Massachusetts General Hospital & Harvard Medical School debriefs with host Dr. Jack West about key ASCO 2019 findings in EGFR mutation-positive NSCLC & her campaign for the IASLC Board of Directors. Fri, 14 Jun 2019 11:00:00 +0000 Lecia Sequist, MD, MPH of Massachusetts General Hospital & Harvard Medical School speaks with Dr. Jack West about the trajectory of her early career and focusing on both the science of medicine & practical concerns while speaking out on social media.

]]> Lecia Sequist, MD, MPH of Massachusetts General Hospital & Harvard Medical School speaks with Dr. Jack West about the trajectory of her early career and focusing on both the science of medicine & practical concerns while speaking out on social media.

]]> 27:09 false 30 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDLecia Sequist, MD, MPH of Massachusetts General Hospital & Harvard Medical School speaks with Dr. Jack West about the trajectory of her early career and focusing on both the science of medicine & practical concerns while speaking out on social media. Tue, 11 Jun 2019 11:00:00 +0000 Dr. Sumanta (Monty) Pal of City of Hope Comprehensive Cancer Center describes his precocious entry into medicine, the tremendous opportunities it has afforded him in ASCO leadership and GU oncology, his commitment to mentorship, & his work/life balance.

]]> Dr. Sumanta (Monty) Pal of City of Hope Comprehensive Cancer Center describes his precocious entry into medicine, the tremendous opportunities it has afforded him in ASCO leadership and GU oncology, his commitment to mentorship, & his work/life balance.

]]> 32:12 false 29 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Sumanta (Monty) Pal of City of Hope Comprehensive Cancer Center describes his precocious entry into medicine, the tremendous opportunities it has afforded him in ASCO leadership and GU oncology, his commitment to mentorship, & his work/life balance. Fri, 07 Jun 2019 11:00:00 +0000 Drs. Heather Wakelee and Jack West review how she entered & became a leader in thoracic oncology, her prioritization of mentorship, & her efforts to continue the strong momentum of the International Association of the Study of Lung Cancer (IASLC).

]]> Drs. Heather Wakelee and Jack West review how she entered & became a leader in thoracic oncology, her prioritization of mentorship, & her efforts to continue the strong momentum of the International Association of the Study of Lung Cancer (IASLC).

]]> 30:28 false 28 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDrs. Heather Wakelee and Jack West review how she entered & became a leader in thoracic oncology, her prioritization of mentorship, & her efforts to continue the strong momentum of the International Association of the Study of Lung Cancer (IASLC). Tue, 04 Jun 2019 11:00:00 +0000 Dr. West speaks with Dr. Ross Camidge about the experience of contributing to the NCCN guidelines, developing the ATOMIC network as a novel platform for lung cancer research, & the increasing importance of online patient molecularly defined groups.

]]> Dr. West speaks with Dr. Ross Camidge about the experience of contributing to the NCCN guidelines, developing the ATOMIC network as a novel platform for lung cancer research, & the increasing importance of online patient molecularly defined groups.

]]> 10:26 false 27 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. West speaks with Dr. Ross Camidge about the experience of contributing to the NCCN guidelines, developing the ATOMIC network as a novel platform for lung cancer research, & the increasing importance of online patient molecularly defined groups. Fri, 31 May 2019 11:00:00 +0000 Dr. Ross Camidge from the University of Colorado discusses his career trajectory, how cancer research in narrow molecularly defined populations has evolved, challenges in molecular oncology practice, & the brain as a new frontier for treatment efficacy.

]]> Dr. Ross Camidge from the University of Colorado discusses his career trajectory, how cancer research in narrow molecularly defined populations has evolved, challenges in molecular oncology practice, & the brain as a new frontier for treatment efficacy.

]]> 24:41 false 26 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Ross Camidge from the University of Colorado discusses his career trajectory, how cancer research in narrow molecularly defined populations has evolved, challenges in molecular oncology practice, & the brain as a new frontier for treatment efficacy. Tue, 28 May 2019 11:00:00 +0000 Dr. Mark Lewis and host Jack West reflect on the personal decisions involved with having children with the uncertainty of a familial cancer syndrome, as well as the power of connectivity through medical discussions on social media.

]]> Dr. Mark Lewis and host Jack West reflect on the personal decisions involved with having children with the uncertainty of a familial cancer syndrome, as well as the power of connectivity through medical discussions on social media.

]]> 24:06 false 25 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Mark Lewis and host Jack West reflect on the personal decisions involved with having children with the uncertainty of a familial cancer syndrome, as well as the power of connectivity through medical discussions on social media. Fri, 24 May 2019 11:00:00 +0000 Dr Jack West & guest Mark Lewis discuss the evolution of his cancer as his care evolves from watchful waiting to a decision to pursue a Whipple procedure, the challenges of recovery, & his approach to discussing his own experiences with his patients.

]]> Dr Jack West & guest Mark Lewis discuss the evolution of his cancer as his care evolves from watchful waiting to a decision to pursue a Whipple procedure, the challenges of recovery, & his approach to discussing his own experiences with his patients.

]]> 19:28 false 24 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr Jack West & guest Mark Lewis discuss the evolution of his cancer as his care evolves from watchful waiting to a decision to pursue a Whipple procedure, the challenges of recovery, & his approach to discussing his own experiences with his patients. Tue, 21 May 2019 11:00:00 +0000 Dr. Mark Lewis and host Jack West trace back from his father's surprise diagnosis of cancer to his own path into medicine, ultimately his self-diagnosis with a familial genetic syndrome.

]]> Dr. Mark Lewis and host Jack West trace back from his father's surprise diagnosis of cancer to his own path into medicine, ultimately his self-diagnosis with a familial genetic syndrome.

]]> 23:16 false 23 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Mark Lewis and host Jack West trace back from his father's surprise diagnosis of cancer to his own path into medicine, ultimately his self-diagnosis with a familial genetic syndrome. Fri, 17 May 2019 11:00:00 +0000 Dr. Greg Riely from MSKCC and Dr. Jack West review the changing role for plasma NGS and local ablation therapy (LAT) for oligometastic disease (OMD) or oligoprogressing advanced NSCLC in clinical practice.

]]> Dr. Greg Riely from MSKCC and Dr. Jack West review the changing role for plasma NGS and local ablation therapy (LAT) for oligometastic disease (OMD) or oligoprogressing advanced NSCLC in clinical practice.

]]> 28:12 false 22 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Greg Riely from MSKCC and Dr. Jack West review the changing role for plasma NGS and local ablation therapy (LAT) for oligometastic disease (OMD) or oligoprogressing advanced NSCLC in clinical practice. Tue, 14 May 2019 11:00:00 +0000 Dr. Greg Riely from Memorial Sloan-Kettering Cancer Center (MSKCC) chats with Dr. Jack West about current standards in molecular testing for advanced NSCLC & potential challenges in execution in translating the promise of genomics into broad practice.

]]> Dr. Greg Riely from Memorial Sloan-Kettering Cancer Center (MSKCC) chats with Dr. Jack West about current standards in molecular testing for advanced NSCLC & potential challenges in execution in translating the promise of genomics into broad practice.

]]> 27:18 false 21 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Greg Riely from Memorial Sloan-Kettering Cancer Center (MSKCC) chats with Dr. Jack West about current standards in molecular testing for advanced NSCLC & potential challenges in execution in translating the promise of genomics into broad practice. Fri, 10 May 2019 11:00:00 +0000 Dr. Jack West & pulmonary pathologist Sanjay Mukhopadhyay, MD from the Cleveland Clinic discuss changing workflows in pathology introduced by artificial intelligence, telemedicine, & new digital platforms for education & support.

]]> Dr. Jack West & pulmonary pathologist Sanjay Mukhopadhyay, MD from the Cleveland Clinic discuss changing workflows in pathology introduced by artificial intelligence, telemedicine, & new digital platforms for education & support.

]]> 27:18 false 20 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Jack West & pulmonary pathologist Sanjay Mukhopadhyay, MD from the Cleveland Clinic discuss changing workflows in pathology introduced by artificial intelligence, telemedicine, & new digital platforms for education & support. Tue, 07 May 2019 11:00:00 +0000 Dr. Sanjay Mukhopadhyay, pathologist at Cleveland Clinic, speaks with Dr. Jack West about the strong pathology community on Twitter and how social media are providing new opportunities to share information and create broader medical communities.

]]> Dr. Sanjay Mukhopadhyay, pathologist at Cleveland Clinic, speaks with Dr. Jack West about the strong pathology community on Twitter and how social media are providing new opportunities to share information and create broader medical communities.

]]> 26:14 false 19 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Sanjay Mukhopadhyay, pathologist at Cleveland Clinic, speaks with Dr. Jack West about the strong pathology community on Twitter and how social media are providing new opportunities to share information and create broader medical communities. Fri, 03 May 2019 11:00:00 +0000 Dr. Bishal Gyawali and Dr. Jack West discuss the concept of a "cancer ground-shot," challenges to enforce common sense in oncology, and questions about low standards for FDA approvals that may not truly improve outcomes for patients with cancer.

]]> Dr. Bishal Gyawali and Dr. Jack West discuss the concept of a "cancer ground-shot," challenges to enforce common sense in oncology, and questions about low standards for FDA approvals that may not truly improve outcomes for patients with cancer.

]]> 20:41 false 18 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Bishal Gyawali and Dr. Jack West discuss the concept of a "cancer ground-shot," challenges to enforce common sense in oncology, and questions about low standards for FDA approvals that may not truly improve outcomes for patients with cancer. Tue, 30 Apr 2019 11:00:00 +0000 Dr. Bishal Gyawali speaks with Dr. West about his trajectory from medical trainee in Nepal to an international authority on evidence-based cancer care, how his path has shaped his professional priorities, & how social media has provided new opportunities.

]]> Dr. Bishal Gyawali speaks with Dr. West about his trajectory from medical trainee in Nepal to an international authority on evidence-based cancer care, how his path has shaped his professional priorities, & how social media has provided new opportunities.

]]> 19:52 false 17 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Bishal Gyawali speaks with Dr. West about his trajectory from medical trainee in Nepal to an international authority on evidence-based cancer care, how his path has shaped his professional priorities, & how social media has provided new opportunities. Fri, 26 Apr 2019 11:00:00 +0000 Dr. Charu Aggarwal discusses with Dr. West how she and her colleagues at Univ. of Pennsylvania can develop their own careers alongside each other, #medTwitter, how she navigates work-life balance, & the improving support for women in heme/onc.

]]> Dr. Charu Aggarwal discusses with Dr. West how she and her colleagues at Univ. of Pennsylvania can develop their own careers alongside each other, #medTwitter, how she navigates work-life balance, & the improving support for women in heme/onc.

]]> 16:02 false 16 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Charu Aggarwal discusses with Dr. West how she and her colleagues at Univ. of Pennsylvania can develop their own careers alongside each other, #medTwitter, how she navigates work-life balance, & the improving support for women in heme/onc. Tue, 23 Apr 2019 11:00:00 +0000 Dr. West & Charu Aggarwal from University of Pennsylvania reviews data from her own group & other centers, demonstrating increasing practical utility & remaining limitations of liquid biopsy testing for molecular markers in advanced NSCLC.

]]> Dr. West & Charu Aggarwal from University of Pennsylvania reviews data from her own group & other centers, demonstrating increasing practical utility & remaining limitations of liquid biopsy testing for molecular markers in advanced NSCLC.

]]> 26:53 false 15 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. West & Charu Aggarwal from University of Pennsylvania reviews data from her own group & other centers, demonstrating increasing practical utility & remaining limitations of liquid biopsy testing for molecular markers in advanced NSCLC. Fri, 19 Apr 2019 11:00:00 +0000 Dr. Jack West reviews why the new FDA approval of first line pembrolizumab monotherapy for the 1-49% PD-L1 subgroup won on a technicality and now offers a clearly inferior choice compared to far better existing standards for patients with low tumor PD-L1.

]]> Dr. Jack West reviews why the new FDA approval of first line pembrolizumab monotherapy for the 1-49% PD-L1 subgroup won on a technicality and now offers a clearly inferior choice compared to far better existing standards for patients with low tumor PD-L1.

]]> 20:09 false 14 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Jack West reviews why the new FDA approval of first line pembrolizumab monotherapy for the 1-49% PD-L1 subgroup won on a technicality and now offers a clearly inferior choice compared to far better existing standards for patients with low tumor PD-L1. Tue, 16 Apr 2019 11:00:00 +0000 Drs. Jed Gorden and Jack West reflect on the evolving field of interventional pulmonology and their role not only in performing biopsies but also in longitudinally managing pleural effusions and pulmonary complications in patients with lung cancer.

]]> Drs. Jed Gorden and Jack West reflect on the evolving field of interventional pulmonology and their role not only in performing biopsies but also in longitudinally managing pleural effusions and pulmonary complications in patients with lung cancer.

]]> 20:09 false 13 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDrs. Jed Gorden and Jack West reflect on the evolving field of interventional pulmonology and their role not only in performing biopsies but also in longitudinally managing pleural effusions and pulmonary complications in patients with lung cancer. Fri, 12 Apr 2019 11:00:00 +0000 Dr. Jed Gorden speaks with Dr. Jack West, reviewing the obstacles limiting broader adoption of lung cancer screening in practice and how novel approaches are needed to reach areas outside of tertiary care hospitals.

]]> Dr. Jed Gorden speaks with Dr. Jack West, reviewing the obstacles limiting broader adoption of lung cancer screening in practice and how novel approaches are needed to reach areas outside of tertiary care hospitals.

]]> 25:41 false 12 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Jed Gorden speaks with Dr. Jack West, reviewing the obstacles limiting broader adoption of lung cancer screening in practice and how novel approaches are needed to reach areas outside of tertiary care hospitals. Tue, 09 Apr 2019 11:00:00 +0000 Drs. Jack West & Corey Langer debate the criteria for adopting early clinical data as practice-changing as immunotherapy trials in locally advanced & metastatic NSCLC are reported.

]]> Drs. Jack West & Corey Langer debate the criteria for adopting early clinical data as practice-changing as immunotherapy trials in locally advanced & metastatic NSCLC are reported.

]]> 19:06 false 9 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDrs. Jack West & Corey Langer debate the criteria for adopting early clinical data as practice-changing as immunotherapy trials in locally advanced & metastatic NSCLC are reported. Fri, 05 Apr 2019 11:00:00 +0000 Dr. Jack West & Sweden-based Dr. Gil Morgan discuss disparities in access & overall quality of cancer care, challenges in smoking cessation efforts, & the limited impact of lung cancer screening internationally.

]]> Dr. Jack West & Sweden-based Dr. Gil Morgan discuss disparities in access & overall quality of cancer care, challenges in smoking cessation efforts, & the limited impact of lung cancer screening internationally.

]]> 25:18 false 10 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Jack West & Sweden-based Dr. Gil Morgan discuss disparities in access & overall quality of cancer care, challenges in smoking cessation efforts, & the limited impact of lung cancer screening internationally. Tue, 02 Apr 2019 11:00:00 +0000 Dr. Jack West & Sweden-based Dr. Gil Morgan reflect on how social media are forging new conversations & educational opportunities for the global oncology community, as well as the marked differences in cancer care & medical practice in the US vs. Sweden.

]]> Dr. Jack West & Sweden-based Dr. Gil Morgan reflect on how social media are forging new conversations & educational opportunities for the global oncology community, as well as the marked differences in cancer care & medical practice in the US vs. Sweden.

]]> 22:42 false 9 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Jack West & Sweden-based Dr. Gil Morgan reflect on how social media are forging new conversations & educational opportunities for the global oncology community, as well as the marked differences in cancer care & medical practice in the US vs. Sweden. Fri, 29 Mar 2019 11:00:00 +0000 Drs. Jack West & Giorgio Scagliotti discuss the rapid evolution of lung cancer management as well as the practical bottlenecks & challenges limiting the quality of lung cancer care globally.

]]> Drs. Jack West & Giorgio Scagliotti discuss the rapid evolution of lung cancer management as well as the practical bottlenecks & challenges limiting the quality of lung cancer care globally.

]]> 17:43 false 8 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDrs. Jack West & Giorgio Scagliotti discuss the rapid evolution of lung cancer management as well as the practical bottlenecks & challenges limiting the quality of lung cancer care globally. Tue, 26 Mar 2019 11:00:00 +0000 Drs. Jack West & Alex Drilon, from Memorial Sloan-Kettering, discuss opportunities & challenges of studying narrow molecularly-defined patient subgroups, (MET, RET, TRK, & others), along with the increasingly active role of online patient groups.

]]> Drs. Jack West & Alex Drilon, from Memorial Sloan-Kettering, discuss opportunities & challenges of studying narrow molecularly-defined patient subgroups, (MET, RET, TRK, & others), along with the increasingly active role of online patient groups.

]]> 12:18 false 7 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDrs. Jack West & Alex Drilon, from Memorial Sloan-Kettering, discuss opportunities & challenges of studying narrow molecularly-defined patient subgroups, (MET, RET, TRK, & others), along with the increasingly active role of online patient groups. Fri, 22 Mar 2019 11:00:00 +0000 Dr. Jack West & guests, Drs. Christine Hann from Johns Hopkins & Stephen Liu from Georgetown, review recent potentially practice-changing results in small cell lung cancer (SCLC) & consider the challenges & future prospects for the SCLC landscape.

]]> Dr. Jack West & guests, Drs. Christine Hann from Johns Hopkins & Stephen Liu from Georgetown, review recent potentially practice-changing results in small cell lung cancer (SCLC) & consider the challenges & future prospects for the SCLC landscape.

]]> 23:46 false 6 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Jack West & guests, Drs. Christine Hann from Johns Hopkins & Stephen Liu from Georgetown, review recent potentially practice-changing results in small cell lung cancer (SCLC) & consider the challenges & future prospects for the SCLC landscape. Tue, 19 Mar 2019 11:00:00 +0000 Dr. Jack West connects with Dr. Matthew Gubens of UCSF, discussing practicing oncology in the Bay Area, telemedicine in the cancer clinic, emerging data supportig plasma NGS in advanced NSCLC, & struggling to maintain work-life balance.

]]> Dr. Jack West connects with Dr. Matthew Gubens of UCSF, discussing practicing oncology in the Bay Area, telemedicine in the cancer clinic, emerging data supportig plasma NGS in advanced NSCLC, & struggling to maintain work-life balance.

]]> 20:58 false 5 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Jack West connects with Dr. Matthew Gubens of UCSF, discussing practicing oncology in the Bay Area, telemedicine in the cancer clinic, emerging data supportig plasma NGS in advanced NSCLC, & struggling to maintain work-life balance. Fri, 15 Mar 2019 11:00:00 +0000 Drs. Jack West & Joan Schiller discuss explosive changes in treating lung cancer, her role in developing a thriving nonprofit, challenges for women in academic medicine, stigma vs. lung cancer patients, & the growing influence of online patient groups.

]]> Drs. Jack West & Joan Schiller discuss explosive changes in treating lung cancer, her role in developing a thriving nonprofit, challenges for women in academic medicine, stigma vs. lung cancer patients, & the growing influence of online patient groups.

]]> 19:08 false 4 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDrs. Jack West & Joan Schiller discuss explosive changes in treating lung cancer, her role in developing a thriving nonprofit, challenges for women in academic medicine, stigma vs. lung cancer patients, & the growing influence of online patient groups. Tue, 12 Mar 2019 11:00:00 +0000 Dr. Jack West speaks with thoracic oncology global leader, Dr. David Gandara, on his role in mentoring junior colleagues, the evolution of clinical trials under his leadership of the Lung Cancer Committee of SWOG, & the new opportunities presented by blood-based testing for biomarkers.

]]> Dr. Jack West speaks with thoracic oncology global leader, Dr. David Gandara, on his role in mentoring junior colleagues, the evolution of clinical trials under his leadership of the Lung Cancer Committee of SWOG, & the new opportunities presented by blood-based testing for biomarkers.

]]> 22:31 false 3 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Jack West speaks with thoracic oncology global leader, Dr. David Gandara, on his role in mentoring junior colleagues, the evolution of clinical trials under his leadership of the Lung Cancer Committee of SWOG, & the new opportunities presented by blood-based testing for biomarkers. Fri, 08 Mar 2019 12:00:00 +0000 Dr. Jack West interviews Dr. David Spigel of Sarah Cannon Research Institute on the evidence on an optimal duration of immunotherapy for long-responding patients with advanced NSCLC, weighing efficacy, potential toxicity, and cost concerns.

]]> Dr. Jack West interviews Dr. David Spigel of Sarah Cannon Research Institute on the evidence on an optimal duration of immunotherapy for long-responding patients with advanced NSCLC, weighing efficacy, potential toxicity, and cost concerns.

]]> 20:37 false 2 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Jack West interviews Dr. David Spigel of Sarah Cannon Research Institute on the evidence on an optimal duration of immunotherapy for long-responding patients with advanced NSCLC, weighing efficacy, potential toxicity, and cost concerns. Tue, 05 Mar 2019 09:00:00 +0000 Dr. Jack West interviews Dr. David Spigel of Sarah Cannon Research Institute on the challenges of conducting clinical trials and delivering increasingly complex patient care, along with the possible future role of artificial intelligence and telemedicine.

]]> Dr. Jack West interviews Dr. David Spigel of Sarah Cannon Research Institute on the challenges of conducting clinical trials and delivering increasingly complex patient care, along with the possible future role of artificial intelligence and telemedicine.

]]> 24:33 false 1 full WestWindPodcast@BeaconMedIC.com (Howard (Jack) West, MD)Howard (Jack) West, MDDr. Jack West interviews Dr. David Spigel of Sarah Cannon Research Institute on the challenges of conducting clinical trials and delivering increasingly complex patient care, along with the possible future role of artificial intelligence and telemedicine.